211 related articles for article (PubMed ID: 21527894)
21. Circulating markers of inflammation and their link to indices of adiposity.
Browning LM; Krebs JD; Magee EC; Frühbeck G; Jebb SA
Obes Facts; 2008; 1(5):259-65. PubMed ID: 20054187
[TBL] [Abstract][Full Text] [Related]
22. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial.
Christie DR; Grant J; Darnell BE; Chapman VR; Gastaldelli A; Sites CK
Am J Obstet Gynecol; 2010 Aug; 203(2):153.e1-9. PubMed ID: 20435291
[TBL] [Abstract][Full Text] [Related]
23. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal.
Sites CK; Toth MJ; Cushman M; L'Hommedieu GD; Tchernof A; Tracy RP; Poehlman ET
Fertil Steril; 2002 Jan; 77(1):128-35. PubMed ID: 11779602
[TBL] [Abstract][Full Text] [Related]
24. Age-related changes in insulin sensitivity and β-cell function among European-American and African-American women.
Chandler-Laney PC; Phadke RP; Granger WM; Fernández JR; Muñoz JA; Man CD; Cobelli C; Ovalle F; Gower BA
Obesity (Silver Spring); 2011 Mar; 19(3):528-35. PubMed ID: 20885386
[TBL] [Abstract][Full Text] [Related]
25. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects.
Möller K; Ostermann AI; Rund K; Thoms S; Blume C; Stahl F; Hahn A; Schebb NH; Schuchardt JP
Prostaglandins Leukot Essent Fatty Acids; 2016 Mar; 106():39-49. PubMed ID: 26751601
[TBL] [Abstract][Full Text] [Related]
26. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
[TBL] [Abstract][Full Text] [Related]
27. Indices of adiposity as predictors of cardiometabolic risk and inflammation in young adults.
Pourshahidi LK; Wallace JM; Mulhern MS; Horigan G; Strain JJ; McSorley EM; Magee PJ; Bonham MP; Livingstone MB
J Hum Nutr Diet; 2016 Feb; 29(1):26-37. PubMed ID: 25677964
[TBL] [Abstract][Full Text] [Related]
28. Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity.
Bastard JP; Jardel C; Bruckert E; Vidal H; Hainque B
Diabetes Obes Metab; 2000 Oct; 2(5):323-5. PubMed ID: 11225749
[TBL] [Abstract][Full Text] [Related]
29. Association between inflammatory and obesity markers in a Swiss population-based sample (CoLaus Study).
Marques-Vidal P; Bochud M; Bastardot F; Lüscher T; Ferrero F; Gaspoz JM; Paccaud F; Urwyler A; von Känel R; Hock C; Waeber G; Preisig M; Vollenweider P
Obes Facts; 2012; 5(5):734-44. PubMed ID: 23108472
[TBL] [Abstract][Full Text] [Related]
30. Inflammation and race and gender differences in computerized tomography-measured adipose depots.
Beasley LE; Koster A; Newman AB; Javaid MK; Ferrucci L; Kritchevsky SB; Kuller LH; Pahor M; Schaap LA; Visser M; Rubin SM; Goodpaster BH; Harris TB;
Obesity (Silver Spring); 2009 May; 17(5):1062-9. PubMed ID: 19165157
[TBL] [Abstract][Full Text] [Related]
31. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo.
Mohamed-Ali V; Goodrick S; Bulmer K; Holly JM; Yudkin JS; Coppack SW
Am J Physiol; 1999 Dec; 277(6):E971-5. PubMed ID: 10600783
[TBL] [Abstract][Full Text] [Related]
32. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study.
Panagiotakos DB; Pitsavos C; Yannakoulia M; Chrysohoou C; Stefanadis C
Atherosclerosis; 2005 Dec; 183(2):308-15. PubMed ID: 16285994
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in inflammatory markers: what is the contribution of visceral adiposity?
Cartier A; Côté M; Lemieux I; Pérusse L; Tremblay A; Bouchard C; Després JP
Am J Clin Nutr; 2009 May; 89(5):1307-14. PubMed ID: 19297456
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for insulin resistance in midlife Singaporean women.
Sundström-Poromaa I; Thu WPP; Kramer MS; Logan S; Cauley JA; Yong EL
Maturitas; 2020 Jul; 137():50-56. PubMed ID: 32498937
[TBL] [Abstract][Full Text] [Related]
35. Diet-induced changes in intra-abdominal adipose tissue and CVD risk in American women.
Katsoulis K; Blaudeau TE; Roy JP; Hunter GR
Obesity (Silver Spring); 2009 Dec; 17(12):2169-75. PubMed ID: 19444234
[TBL] [Abstract][Full Text] [Related]
36. Weight loss reduces C-reactive protein levels in obese postmenopausal women.
Tchernof A; Nolan A; Sites CK; Ades PA; Poehlman ET
Circulation; 2002 Feb; 105(5):564-9. PubMed ID: 11827920
[TBL] [Abstract][Full Text] [Related]
37. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women.
Chacko SA; Song Y; Nathan L; Tinker L; de Boer IH; Tylavsky F; Wallace R; Liu S
Diabetes Care; 2010 Feb; 33(2):304-10. PubMed ID: 19903755
[TBL] [Abstract][Full Text] [Related]
38. Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV Infection.
Leng SX; Dandorf S; Li H; Carlson J; Hui J; Mehta SH; Piggott D; Islam S; Manwani B; Kirk GD
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1257-64. PubMed ID: 26414536
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
Samy N; Hashim M; Sayed M; Said M
Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
[TBL] [Abstract][Full Text] [Related]
40. IL-6 and Soluble Receptors in Overweight and Obese African American Women With and Without Breast Cancer.
Griffith KA; Ryan AS
Biol Res Nurs; 2021 Apr; 23(2):218-222. PubMed ID: 32748635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
